//Orphan Drug Manufacture
Orphan Drug Manufacture 2017-08-04T13:50:28+00:00

Orphan Drug Manufacture

Our enviable 30 year track record offering development and scale up services in THE PHARMACEUTICAL industry makes HIGH FORCE RESEARCH ideally placed to provide orphan drug manufacture for the treatment of rare diseases.

Our facilities include two segregated ISO Class 8 laboratories in which multi-stage synthesis to cGMP standards is carried out. Each facility operates at a 30 litre scale, typically enabling production in batches of up to multi kilo quantities

We have been inspected by the MHRA and are in compliance with the principles and guidelines of good manufacturing practice as regulated by ICH Q7 and Eudralex volume 4 part II for clinical trials.